| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |